Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Sakuma

Showing results (191-200 of 257) with videos related to

Pageof 26
Sort By:
International Heart Journal|February 23, 2013
Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART studyTsutomu Yamazaki, Ryuji Nohara, Hiroyuki Daida, et al.
International Heart Journal|March 18, 2014
Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART studyHiroyoshi Yokoi, Ryuji Nohara, Hiroyuki Daida, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 19, 2011
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) studyRyuji Nohara, Hiroyuki Daida, Mitsumasa Hata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 15, 2013
Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension studyRyuji Nohara, Hiroyuki Daida, Mitsumasa Hata, et al.
Journal of Atherosclerosis and Thrombosis|March 11, 2010
Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART studyMasahiko Kurabayashi, Ichiro Sakuma, Ryuzo Kawamori, et al.
Journal of Atherosclerosis and Thrombosis|June 24, 2014
Can intensive lipid-lowering therapy improve the carotid intima-media thickness in Japanese subjects under primary prevention for cardiovascular disease?: The JART and JART extension subanalysisHiroyuki Daida, Ryuji Nohara, Mitsumasa Hata, et al.
Frontiers in Endocrinology|October 19, 2020
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes MellitusMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Journal of Pharmacological Sciences|December 16, 2010
Bepridil facilitates early termination of spiral-wave reentry in two-dimensional cardiac muscle through an increase of intercellular electrical couplingHiroki Takanari, Haruo Honjo, Yoshio Takemoto, et al.
International Journal of Cardiology|July 20, 2015
Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemiaKwang Kon Koh, Pyung Chun Oh, Ichiro Sakuma, et al.
European Journal of Pharmacology|August 11, 2007
Antagonism of endothelin action normalizes altered levels of VEGF and its signaling in the brain of stroke-prone spontaneously hypertensive ratSubrina Jesmin, Seiji Maeda, Chishimba N Mowa, et al.
Pageof 26

Showing results (191-200 of 257) with videos related to

Sort By:
Pageof 26
International Heart Journal|February 23, 2013
Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART studyTsutomu Yamazaki, Ryuji Nohara, Hiroyuki Daida, et al.
International Heart Journal|March 18, 2014
Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART studyHiroyoshi Yokoi, Ryuji Nohara, Hiroyuki Daida, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 19, 2011
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) studyRyuji Nohara, Hiroyuki Daida, Mitsumasa Hata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 15, 2013
Effect of long-term intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness--Justification for Atherosclerosis Regression Treatment (JART) extension studyRyuji Nohara, Hiroyuki Daida, Mitsumasa Hata, et al.
Journal of Atherosclerosis and Thrombosis|March 11, 2010
Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART studyMasahiko Kurabayashi, Ichiro Sakuma, Ryuzo Kawamori, et al.
Journal of Atherosclerosis and Thrombosis|June 24, 2014
Can intensive lipid-lowering therapy improve the carotid intima-media thickness in Japanese subjects under primary prevention for cardiovascular disease?: The JART and JART extension subanalysisHiroyuki Daida, Ryuji Nohara, Mitsumasa Hata, et al.
Frontiers in Endocrinology|October 19, 2020
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes MellitusMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
Journal of Pharmacological Sciences|December 16, 2010
Bepridil facilitates early termination of spiral-wave reentry in two-dimensional cardiac muscle through an increase of intercellular electrical couplingHiroki Takanari, Haruo Honjo, Yoshio Takemoto, et al.
International Journal of Cardiology|July 20, 2015
Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemiaKwang Kon Koh, Pyung Chun Oh, Ichiro Sakuma, et al.
European Journal of Pharmacology|August 11, 2007
Antagonism of endothelin action normalizes altered levels of VEGF and its signaling in the brain of stroke-prone spontaneously hypertensive ratSubrina Jesmin, Seiji Maeda, Chishimba N Mowa, et al.
Pageof 26